URL of this page: http://www.nlm.nih.gov/medlineplus/ency/article/000856.htm
Alternative names
Deerfly fever; Rabbit fever; Pahvant Valley plague; Ohara disease; Yatobyo (Japan); Lemming feverDefinition
Tularemia is an infection common in wild rodents. It is caused by the organism Francisella tularensis. Tularemia is transmitted to humans by contact with infected animal tissues or by ticks, biting flies, and mosquitoes.
Causes, incidence, and risk factors
Humans can contract tularemia in the following ways:
Endemic areas (areas where the disorder occurs most commonly) include North America and parts of Europe and Asia. The illness may continue for several weeks after symptoms begin.
Some people may develop an atypical pneumonia after infection. Risk factors include recent exposure to rabbits or a recent tick bite. The disease is very rare in the United States.
Francisella tularensis is considered a potential bioterrorism agent. An aerosol release would be a possible method of infection, and would result in pneumonia cases, beginning 1 - 10 days after exposure.
Symptoms
Signs and tests
This disease may also alter the results of febrile/cold agglutinins.
Treatment
The goal of treatment is to cure the infection with antibiotic treatment. Streptomycin and tetracycline are commonly used to treat this infection. Once daily gentamycin treatment has been tried with excellent results as an alternative therapy to streptomycin, though only a few cases have been studied to date.
Note: oral tetracycline is usually not prescribed for children until after all their permanent teeth have erupted. It can permanently discolor teeth that are still forming.
Expectations (prognosis)
Tularemia is fatal in about 5% of untreated cases, and in less than 1% of treated cases.
Complications
Calling your health care provider
Call your health care provider if symptoms develop after a rodent bite, tick bite, or exposure to the flesh of a wild animal.
Prevention
A vaccine is recommended for people at high risk (trappers, hunters, and laboratory workers who work with the organism).
References
Eliasson H, Broman T, Forsman M, Back E. Tularemia: current epidemiology and disease management. Infect Dis Clin North Am. 2006. Jun;20(2):289-311, ix.
Hassoun A, Spera R, Dunkel J. Tularemia and Once-Daily Gentamicin. Antimicrobial Agents and Chemotherapy 2006; 50(2),824.
Cronquist SD. Tularemia: the disease and the weapon. Dermatol Clin. 2004; 22(3): 313-20, vi-vii.
Long SS, Pickering LK, Prober CG. Principles and Practice of Pediatric Infectious Diseases. 2nd ed. New York, NY: Elsevier; 2003:917.
Cohen J, Powderly WG. Infectious Diseases. 2nd ed. New York, NY: Elsevier; 2004:1649-1653.
Update Date: 1/29/2007 Updated by: D. Scott Smith, M.D., MSc, DTM&H, Chief of Infectious Disease & Geographic Medicine, Kaiser Redwood City, CA & Adjunct Assistant Professor, Stanford University. Review provided by VeriMed Healthcare Network.